An open-label, multi-center, multiple application study of naftifine HCl gel 2% (Naftin) in pediatric patients with tinea pedis.

Trial Profile

An open-label, multi-center, multiple application study of naftifine HCl gel 2% (Naftin) in pediatric patients with tinea pedis.

Completed
Phase of Trial: Phase II

Latest Information Update: 31 Mar 2015

At a glance

  • Drugs Naftifine (Primary)
  • Indications Tinea pedis
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Mar 2015 New trial record
    • 20 Mar 2015 According to Merz Pharma media release, results from this study will be presented at the Annual Meeting of the American Academy of Dermatology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top